Skip to main content
. 2018 Oct 25;23(43):1700732. doi: 10.2807/1560-7917.ES.2018.23.43.1700732

Table 2. Factors associated with intensive care unit admission and death, Catalonia, influenza seasons 2010/11–2015/16 (n = 1,727).

Characteristics ICU/death
(n = 692)
Non-ICU/death (n = 1,035) Crude OR 95% CI p value
n % n %
Seasonal vaccination
Yes 146 21.3 304 29.7 0.64 (0.51 to 0.80) < 0.001
No 540 78.7 721 70.3 Ref
Age
18–64 years 386 55.8 422 40.8 Ref
≥ 65 years 306 44.2 613 59.2 0.55 (0.45 to 0.66) < 0.001
Sex
Male 271 39.2 472 45.6 0.77 (0.63 to 0.93) 0.008
Female 421 60.8 563 54.4 Ref
Type of virus
A 602 87 883 85.3 1.15 (0.87 to 1.52) 0.325
B 90 13 152 14.7 Ref
COPD
Yes 187 27.0 255 24.6 1.13 (0.91 to 1.41) 0.27
No 505 73.0 780 75.4 Ref
Obesity
Yes 87 12.6 95 9.2 1.42 (1.04 to 1.94) 0.02
No 605 87.4 940 90.8 Ref
Diabetes mellitus
Yes 170 24.6 261 25.2 0.97 (0.77 to 1.21) 0.76
No 522 75.4 774 74.8 Ref
Chronic renal disease
Yes 100 14.5 136 13.1 1.12 (0.84 to 1.47) 0.44
No 592 85.5 899 86.9 Ref
Immunodeficiency
Yes 159 23.0 177 17.1 1.45 (1.14 to 1.84) 0.003
No 533 77.0 858 82.9 Ref
Chronic cardiovascular disease
Yes 196 28.3 312 30.1 0.92 (0.74 to 1.13) 0.42
No 496 71.7 723 69.9 Ref
Chronic liver disease
Yes 58 8.4 55 5.3 1.63 (1.11 to 2.39) 0.01
No 634 91.6 980 94.7 Ref
Pregnancy
Yes 16 2.3 10 1.0 2.43 (1.09 to 5.38) 0.03
No 676 97.7 1025 99.0 Ref
NI treatment
Yes 635 91.8 942 91.0 1.10 (0.78 to 1.55) 0.59
≤ 48h symptom onset 154 23.1 283 28.4 0.89 (0.60 to 1.30) 0.54
> 48h symptom onset 455 68.3 619 62.2 1.20 (0.84 to 1.70) 0.31
No 57 8.6 93 9.3 Ref
Number of risk factors
0 172 24.9 270 26.1 0.78 (0.58 to 1.06) 0.11
1 241 34.8 378 36.5 0.78 (0.59 to 1.04) 0.09
2 155 22.4 235 22.7 0.81 (0.62 to 1.10) 0.18
> 2 124 17.9 152 14.7 Ref
Hospital stay
0–7 days 145 21 539 52.1 0.24 (0.197 to 0.30) < 0.001
> 7 days 545 79 145 21 Ref
Hospital stay
0–14 days 335 48.6 859 83 0.19 (0.15 to 2.41) < 0.001
> 14 days 355 51.4 176 17 Ref

CI: confidence interval; COPD: chronic obstructive pulmonary disease; ICU: intensive care unit; NI: Neuraminidase inhibitors; OR: odds ratio; Ref: reference.